Michael Sassano, Founder, CEO, Solaris Farms
Although his exciting career has led him to be involved in the fast-paced worlds of international real estate development, high-level banking, and cutting edge tech-investing, it is the cannabis space where Michael Sassano has always shined the brightest. Michael is well known as one of the original movers and shakers in this sector, celebrated prominently in both mainstream business and cannabis media for his contributions to cultivation technology and as an industry futurist with a proven track record of successfully predicting trends and policy directions.
After years of partnering and investing with many startups in the global cannabis industry, both in the private sector and publicly traded companies, Michael came to the conclusion that greenhouse growing would be the future of large scale cannabis cultivation; this would become a necessary focus to supply the massive medical and recreational markets as legality became widespread. He understood that compared to traditional outdoor growing, hybrid greenhouses provided the ability to produce a large volume of high-quality yields, with a lower cost structure, increased profitability, and even a net positive impact on the environment.
In 2015, he traveled around the world touring different types of agricultural greenhouses and observing the various technologies used to produce high-quality yields in harsh climates. The next year, after watching closely as Nevada fully legalized cannabis and developed its business-friendly legal framework, Michael designed and began development on Solaris Farms utilizing the horticultural knowledge and technological insight he gained from his travels. Today, Solaris is one of a handful of maximum state-approved canopy mega-greenhouses and currently the most technologically-advanced hybrid greenhouse operating in Nevada.
Michael also has a strong vision for the future of European medical cannabis markets. In 2019, he became the Head of the Board of Directors for Somai Pharmaceuticals LTD; the company focuses on the research, development, and distribution of high-quality, cannabinoid-containing, GMP-certified pharmaceutical products throughout the European Union.
https://www.solarisfarms.org/
https://www.linkedin.com/in/michaelsassano3/
https://www.somaipharma.eu/
EPISODE TRANSCRIPT
If you would like a copy of the episode transcript, please reach out to us at transripts@eckfeldt.com for more information.